Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
ABOUT THIS PAGE
93
PharmaCompass offers a list of Dimemorfanphosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dimemorfanphosphate manufacturer or Dimemorfanphosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimemorfanphosphate manufacturer or Dimemorfanphosphate supplier.
PharmaCompass also assists you with knowing the Dimemorfanphosphate API Price utilized in the formulation of products. Dimemorfanphosphate API Price is not always fixed or binding as the Dimemorfanphosphate Price is obtained through a variety of data sources. The Dimemorfanphosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dimemorfan phosphate [JAN] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimemorfan phosphate [JAN], including repackagers and relabelers. The FDA regulates Dimemorfan phosphate [JAN] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimemorfan phosphate [JAN] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dimemorfan phosphate [JAN] supplier is an individual or a company that provides Dimemorfan phosphate [JAN] active pharmaceutical ingredient (API) or Dimemorfan phosphate [JAN] finished formulations upon request. The Dimemorfan phosphate [JAN] suppliers may include Dimemorfan phosphate [JAN] API manufacturers, exporters, distributors and traders.
click here to find a list of Dimemorfan phosphate [JAN] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dimemorfan phosphate [JAN] Drug Master File in Japan (Dimemorfan phosphate [JAN] JDMF) empowers Dimemorfan phosphate [JAN] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dimemorfan phosphate [JAN] JDMF during the approval evaluation for pharmaceutical products. At the time of Dimemorfan phosphate [JAN] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dimemorfan phosphate [JAN] suppliers with JDMF on PharmaCompass.
Dimemorfan phosphate [JAN] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimemorfan phosphate [JAN] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimemorfan phosphate [JAN] GMP manufacturer or Dimemorfan phosphate [JAN] GMP API supplier for your needs.
A Dimemorfan phosphate [JAN] CoA (Certificate of Analysis) is a formal document that attests to Dimemorfan phosphate [JAN]'s compliance with Dimemorfan phosphate [JAN] specifications and serves as a tool for batch-level quality control.
Dimemorfan phosphate [JAN] CoA mostly includes findings from lab analyses of a specific batch. For each Dimemorfan phosphate [JAN] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimemorfan phosphate [JAN] may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimemorfan phosphate [JAN] EP), Dimemorfan phosphate [JAN] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimemorfan phosphate [JAN] USP).
